Why the study?
Does the analysis of natriuretic peptides improve the detection of preclinical diastolic or systolic dysfunction in asymptomatic at-risk primary care patients?
Does the analysis of natriuretic peptides improve the detection of preclinical diastolic or systolic dysfunction in asymptomatic at-risk primary care patients?
Combining clinical data with NT-proBNP provides an efficient screening method to identify preclinical left ventricular dysfunction in at-risk primary care patients, potentially reducing the need for screening echocardiograms.
No takes yet. Share an insight, caveat, or question.
May support NT-proBNP addition to clinical parameters for preclinical LV dysfunction screening in primary care; hypothesis-generating and requires prospective validation.
Lüers et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: